Skip to main content
. 2015 Dec 28;15:1016. doi: 10.1186/s12885-015-2013-3

Fig. 5.

Fig. 5

The ratio of CD8-/CD8+ T-cells among (a) lung cancer patients and controls, (b) according to cancer disease stages, at baseline (T0), 1 month (T1), 3 months (T3), and 6 months (T6)